AVAX Technologies, Inc. Share Price Other OTC
Equities
AVXT
US0534953056
Biotechnology & Medical Research
Sales 2009 | 399K 33.33M | Sales 2010 | 142K 11.89M | Capitalization | 6.29M 525M |
---|---|---|---|---|---|
Net income 2009 | -19M -1.59B | Net income 2010 | -12M -1B | EV / Sales 2009 | 69 x |
Net Debt 2009 | 3.23M 269M | Net Debt 2010 | 3.1M 259M | EV / Sales 2010 | 65.9 x |
P/E ratio 2009 |
-1.24
x | P/E ratio 2010 |
-1.03
x | Employees | - |
Yield 2009 * |
-
| Yield 2010 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Adele Sommerfeld
CEO | Chief Executive Officer | - | 19/15/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Andrew W. Dahl
CHM | Chairman | 79 | 01/99/01 |
Adele Sommerfeld
CEO | Chief Executive Officer | - | 19/15/19 |
Bruno Maruzzo
BRD | Director/Board Member | 71 | - |
1st Jan change | Capi. | |
---|---|---|
+29.03% | 49.18B | |
-0.10% | 42.11B | |
+49.56% | 40.37B | |
-5.26% | 28.85B | |
+11.48% | 26.09B | |
-22.74% | 18.71B | |
+9.06% | 13.26B | |
+30.01% | 12.32B | |
-1.51% | 11.99B |